Addressing the Release and Permeation Challenges of High- T g Drugs in Amorphous Solid Dispersions

View at publisher Summarise with VIRAT
Authors: Dishan D. Shah, Zhuangyan Xu, Gregory T. Knipp, Wenzhan Yang, Stacey Marden, Dedong Wu, Liping Zhou, Lynne S. Taylor
Cited by: 0
References: 66

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

The goal of the current study was to assess the release rate of model high glass transition temperature ( T g ) drugs from amorphous solid dispersions (ASDs) as a function of drug loading, and then to evaluate the permeation rate of the resultant solutions using Caco-2 cells. Ivacaftor and ARV-825 were selected as model drugs and were formulated as ASDs with hydroxypropyl methylcellulose acetate succinate (HPMCAS). Release was found to be very slow or not detectable at higher drug loadings. Dramatically improved release was observed upon addition of 10 wt % glyceryl tributyrate to the ASDs, which reduced T g . Nanosized drug-rich amorphous droplets, generated upon dissolution of ivacaftor ASDs, enhanced the Caco-2 membrane permeation rate, likely by partitioning into the unstirred water layer (UWL) at the surface of the membrane and reducing the concentration gradient across the UWL. The extent of improvement was correlated with the size of droplets: smaller droplets resulted in faster permeation rates. Addition of glyceryl tributyrate, while increasing the release rate, decreased the permeation rate due to formation of larger droplets. In conclusion, the addition of a plasticizer to an ASD containing a high T g drug led to an improvement in release rate but increased the size of drug-rich nanodroplets produced via the release process with unknown potential implications for in vivo performance.

Fields of Study & Subjects

Drug Solubulity and Delivery Systems Advanced Drug Delivery Systems Material Dynamics and Properties

Publication details

Journal / source
Molecular Pharmaceutics
Volume
23
Issue
4
Pages
2385–2397
Publication date
25 March 2026
Language
EN